Rational Design, Synthesis and Cytotoxic Activity of N-(Phenylcarbamoyl)Benzamide on HeLa Cell Lines


  • Bambang Tri Purwanto Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Airlangga, Surabaya
  • Siswandono Siswandono Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Airlangga, Surabaya
  • Suko Hardjono Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Airlangga, Surabaya
  • Dian Triwidiandany Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Airlangga, Surabaya




ADMET, cytotoxic test, molecular docking, molecular dynamics, N- (phenyl carbamoylbenzamide, synthesis


Urea derivatives are extensively used in the pharmaceutical industry. However, the unsatisfactory level of their membrane penetration requires further modification of the structures with stronger lipophillic properties. Phenylurea has a phenyl group that enables easier membrane penetration as a result of stronger pharmacological activity. Activity prediction was conducted by docking experiments and molecular dynamics, performed with Molegro Virtual Docker 5.5 using checkpoint kinase 1 (CHK1) enzyme with ID PDB: 2YWP. ADMET prediction was applied to collect data using the pkCSM tool. N-(phenyl carbamyol)benzamide compounds, modified by the Schotten Baumann method, were synthesized from benzoil chloride reacting with N-phenylurea. For evaluating anticancer activity, the MTT assay method on HeLa cells was used. Derived from the docking experiments, the compound rerank score of the N-(phenylcarbamoyl)benzamide was 72.0603 kcal/mol, lower than that of hydroxyurea, -32.1514 kcal/mol, causing better inhibitory activities against HeLA cell lines due to higher cytotoxic effects. ADMET Predictor was employed, indicating satisfactory compound distribution with a low, favorable metabolism, possessing good excretion and non-toxicity. The synthesized compound was 82% N-(phenyl carbamoyl)benzamide with 0.8 mM IC80, higher than that of hydroxyurea, 4.3 mM. In conclusion, successfully synthesized N-(phenylcarbamoyl)benzamide was proved to have higher cytotoxic effects. The satisfactory values of these compounds indicate that they are promising anticancer drug candidates.


Avendano, C. & Mendez, J.C., Medicinal Chemistry of Anti-Cancer Drugs, 2nd ed., Amsterdam: Elsevier B.V., 2015.

World Health Organization, Cancer, http://www.who.int/mediacentre/ factsheets/fs297/en/, (12 September 2018).

Hardjono, S., Siswandono, S., Purwanto, P. & Win, D., Quantitative Structure-Cytotoxic Activity Relationship 1-(benzoyloxy)urea and Its Derivative, Current Drug Discovery Technologies, 13(2), pp. 1-8, 2016.

Diyah, N.W., Siswandono, S. & Purwanto, B.T., Synthesis, Molecular Docking, and Cytotoxic Activity of N-Ethyl-N-(ethylcarbamoyl)benzamide Derivatives Against MCF-7 Cell Line, Research Journal of Pharmaceutical, Biological, and Chemical Sciences, 8(1S), pp. 164-173, 2016.

Widiandani, T., Arifianti, L. & Siswandono, Synthesis and Cytotoxicity Test on Human Breast Cancer Cell Line (T47D) Of N-(Allylcarbamothyol) Benzamide, International Journal of Pharmaceutical and Clinical Research, 8(Suppl. 5), pp. 372-376, 2016.

Kesuma, D., Siswandono, Purwanto, B.T. & Rudyanto, M., Synthesis of N-(Phenylcarbamothioyl) Benzamide Derivatives and their Cytotoxic Against MCF-7 Cells, Journal of Chinese Pharmaceutical Sciences, 27(10), pp. 665-671, 2018.

Topliss, J.G., Utilization of Operational Schemes for Analog Synthesis in Drug Design, Journal of Medicinal Chemistry, 15, pp. 1006-1009, 1972.

Song, D.Q., Du, N.N., Wang, Y.M., He, W.Y., Jiang, E.Z., Cheng, S.X., Wang, Y.X., Li, Y.H., Wang, Y.P., Li, X. & Jiang, J.D., Synthesis and Activity Evaluation of Phenylurea Derivatives as Potent Antitumor Agents, Bioorganic & Medicinal Chemistry, 17(11), pp. 3873-3878, 2009.

Eldehna, W.M., Hasan, G.S., Al-Rashad, S.T., Al-Werhi, T., Altyar, A.E., Al-Kahtani, H.M., Almehizia, A.A. & Abdel-Aziz, H.A, Synthesis and In Vitro Anticancer Activity of Certain Novel 1-(2-Methyl-6-Arylpyridine-3-Yl)-3-Phenylureas as Apoptosis Inducing Agents, Journal of Enzyme Inhibitor and Medicinal Chemistry, 34(1), pp. 322-332, 2019.

Szafranski, K. & Slawinski, J., Synthesis of Novel 1-(4-Substituted Pyridine-3-Sulfonyl)-3-Phenylureas with Potential Anticancer Activity, Molecules, 20(7), pp. 12029-12044, 2015.

Li, G., Hasvold, L.A., Tao Z.F., Wang, G.T., Gwaltney II, S.L., Patel, J., Kovar, P., Credo, R.B., Chen, Z., Zhang, H., Park, C., Sham, H., Sowin, T., Rosenberg, S.H. & Lin, N.H., Synthesis and Biological Evaluation of 1-(2,4,5-Trisubstituted Phenyl)-3-(5-Cyanopyrazin-2-Yl)Ureas as Potent CHK1 Kinase Inhibitors, Bioorganic & Medicinal Chemistry Letters, 16, pp. 2293-2298, 2006.

Siswandono. S., Pengembangan Obat Baru, Airlangga University Press, Surabaya, 2016. (Text in Indonesia)

Widiandani, T., Siswandono, Meiyanto, E., Purwanto, B.T., Sulistyowati, M.I. & Hardjono, S., New N-Allylthiourea Derivatives: Synthesis, Molecular Docking and In vitro Cytotoxicity Studies, Tropical Journal of Pharmaceutical and Research, 17(8), pp. 1607-1613, 2018.

CLCbio, Molegro Virtual Docker User Manual, Molegro - A CLC Bio Company, 2013.

Fischer, A., Sellner, M., Neranjan, S., Lill, M.A. & Smieako, M., Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 687 Million Compounds, ChemRxiv Preprint, 2020. DOI: 10.26434/CHEMRXIV.11923239.V1

Salomon-Ferrer, R., Case, D.A. & Walker, R.C., An Overview of the Amber Biomolecular Simulation Package, Wiley Interdisciplinary Reviews: Computational Molecular Science, 3(2), pp. 198-210, 2013. DOI:10.1002/wcms.1121

Miller, B.R., McGee, T.D., Swails, J.M., Homeyer, N., Gohlke, H. & Roitberg, A.E., MMPBSA.py: An Efficient Program for End-state Free Energy Calculations, Journal of Chemical Theory and Computation, 8(9), pp. 3314-3321, 2012. DOI:10.1021/ct300418h

Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C.& Ferrin, T.E., UCSF Chimera - A Visualization System for Exploratory Research and Analysis, Journal of Computational Chemistry, 25(13), pp. 1605-1612, 2004. DOI: 10.1002/jcc.20084

Wang, J., Wang, W., Kollman, P.A. & Case, D.A., Automatic Atom Type and Bond Type Perception in Molecular Mechanical Calculations, Journal of Molecular Graphics and Modelling, 25(2), pp. 247-260, 2006. DOI: 10.1016/j.jmgm.2005.12.005

Ruswanto, Miftah, A.M, Tjahjono, D.H. & Siswandono,Synthesis and In Vitro Cytotoxicity of 1-Benzoyl-3-Methyl Thiourea, Procedia Chemistry, 17, pp. 157-161, 2015.

McMurry, J., Organic Chemistry, 9th ed., Boston: Cengage Learning, 2015.

Purwanto, B.T., Comparison of Suppressive Activity of the Central Nervous System from the New Derivatives N-Benzoylphenylurea, International Journal of Pharmacy and Pharmaceutical Sciences, 6(Suppl.2), pp. 452-455, 2014.

Silverstein, R.M., Webster, F.X, Kiemle, D.J. & Brice, D.L., Spectrofotometric Identification of Organic Compound, 8th ed., New York: John Wiley and Sons, Inc., 2015.

Lipinski, C.A., Lombardo, F., Dominy, B.W. & Feeney, F.J., Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings, Advanced Drug Delivery Reviews, 23, pp. 3-25, 1997.

Imming, P., Medicinal Chemistry: Definitions and Objectives, Drug Activity Phases, Drug Classification Systems, in Wermuth, C.G., Aldous, D., Raboisson, P., Rognan D., eds., The Practice of Medicinal Chemistry, 4th ed., Amsterdam: Elsevier Ltd., 2015.

Pires, D.E.V., Blundell, T.L. & Asher, D.B., pkCSM: Predicting Small Molecules Pharmacokinetics and Toxicity Properties using Graph-Based Signatures, Journal of Medicinal Chemistry, 58(9), pp. 4066-4072, 2015.